At the news
? BEARISHIMPACT 6/10 PRESS-RELEASE filed May 8, 2026 at 10:51 ET
Cytokinetics closed an underwritten public offering of 11.3 million shares at $71.00 per share, raising approximately $805 million in gross proceeds. The offering represents dilution of about 8.7% of the pre-offering market capitalization, which may pressure the stock in the near term as the additional shares enter the market.
- Offering of 11,338,028 shares at $71.00 per share
- Gross proceeds of approximately $805 million
- Full exercise of underwriters' option to purchase additional shares
- Closing of offering announced on May 08, 2026
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access